/ 16 Aug 2016 /
With the adoption of Regulation (EC) No 141/2000 of the European Commission, conditions were created for the development of orphan drugs and, as a result, the Committee for Orphan Medicinal Products has evaluated, since its foundation in 2000, about 2500 requests for naming medical products as orphan drugs. Article by Bruno Sepodes in Public, August 11, 2016 […]
/ 30 Jun 2016 /
Combine both sides of the issue to form a winning strategy in the life sciences sector.
/ 15 Jun 2016 /
P-Bio, through its Executive Director, has been part of the European Banking Authority’s Banking Stakeholder Group in London since April 2016 (representing SMEs), as well as being represented in the Elixir Industry Advisory Committee. Find out more at: www.elixir-europe.org/industry/understanding_industrys_needs www.eba.europa.eu/about-us/organisation/banking-stakeholder-group/members
/ 15 Jun 2016 /
P-BIO encourages its Members to compete in the BIOTECH SME Awards promoted by EuropaBIO.
/ 10 Jun 2016 /
At the invitation of SEBIOT and the Sociedade Portuguesa de Biotecnologia, P-BIO, ASEBIO, Bic Minho and BIOGA co-organized a parallel session dedicated to the companies of Portugal and Spain at BIOIBEROAMERICA, which took place between 5 and 8 June in Salamanca. The session was moderated by P-BIO and took place on 6 June.
/ 15 May 2016 /
P-Bio has maintained a collaboration partnership with the public affairs agency Guess What since May 2016.
/ 10 Apr 2016 /
Entrepreneurship in Health Care, Information Technologies and Davos Conference Debated